Needham & Company LLC Trims Cara Therapeutics (NASDAQ:CARA) Target Price to $5.00
Cara Therapeutics (NASDAQ:CARA – Free Report) had its price target reduced by Needham & Company LLC from $6.00 to $5.00 in a report published on Monday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the biopharmaceutical company’s stock. Several other equities research analysts have also recently commented on the stock. […]
More Stories
Creditcoin Price Down 5.4% Over Last 7 Days (CTC)
Creditcoin (CTC) traded down 1.7% against the US dollar during the 1 day period ending at 14:00 PM Eastern on...
Bitgert Price Down 14.3% This Week (BRISE)
Bitgert (BRISE) traded down 3.7% against the US dollar during the 24-hour period ending at 14:00 PM E.T. on October...
EOS Trading 4.4% Lower Over Last 7 Days (EOS)
EOS (EOS) traded down 3.7% against the US dollar during the 24-hour period ending at 14:00 PM E.T. on October...
Covenant Trading Down 41.1% Over Last Week (COVN)
Covenant (COVN) traded 3.6% lower against the US dollar during the 24 hour period ending at 14:00 PM Eastern on...
Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA) Stock Holdings Trimmed by Elevated Capital Advisors LLC
Elevated Capital Advisors LLC reduced its position in Vanguard FTSE Developed Markets ETF (NYSEARCA:VEA – Free Report) by 0.1% in...
Hartford Investment Management Co. Has $6.83 Million Stock Position in American Tower Co. (NYSE:AMT)
Hartford Investment Management Co. trimmed its position in shares of American Tower Co. (NYSE:AMT – Free Report) by 1.7% during...